QA: Forte Biosciences Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001419041_2023_Forte_Biosciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001419041, Forte Biosciences Inc.

  xvar xval
0 AssetsCurrent 41,511,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 486,000
4 LiabilitiesCurrent 3,179,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,302,000
9 ResearchAndDevelopmentExpense 5,594,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 17,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 41,997,000
1 Liabilities 3,179,000
2 Expenses 13,896,000
3 Revenues 0
4 StockholdersEquity 38,818,000
5 NetIncome -13,879,000
6 ComprehensiveNetIncome -13,879,000
7 BaseVar 29,544,500
8 EconomicCapitalRatio 2.34

Edgar->Model Mapping

Feature Distribution

Change over Time